TipRanks
Go Ultimate55% OFF

Jiutian Chemical Group Limited (C8R) AI Stock Analysis

SG:C8R

Jiutian Chemical Group Limited

(SGX:C8R)

Select Model
Rating:39Underperform
Price Target:SGD 0.01â–¼(-6.67% Downside)
Action:reiterated
Date:08/25/26

The overall score is severely depressed by the company's operational distress, with collapsing revenues, deeply negative margins, and unsustainable cash burn. The balance sheet offers only a temporary buffer as equity rapidly erodes. Technicals confirm a persistent downtrend with no bullish reversal signals, and the negative P/E ratio underscores the lack of earnings power. The primary risk is continued financial deterioration without a clear turnaround catalyst.

Positive Factors
Moderate and Improving LeverageModerate and improving leverage provides a measure of financial flexibility relative to a more highly indebted balance sheet. If maintained, the lower debt burden can reduce financing strain and leave greater capacity to manage volatility or support operations during the next several quarters.
Negative Factors
Severe Revenue DeclineA material multi-year revenue contraction weakens operating scale and makes fixed costs harder to absorb. Continued shrinking sales can reduce customer reach, limit purchasing and production efficiency, and undermine the company’s ability to rebuild profitability over the next several quarters without a durable demand recovery.

Jiutian Chemical Group Limited (C8R) vs. iShares MSCI Singapore ETF (EWS)

-60%-40%-20%0%20%40%SG:C8R-44.44%EWS+12.33%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
SGD 29.83M
Dividend Yield
―
Average Volume (3M)
916.06K
Price to Earnings (P/E)
-0.6
Beta (1Y)
1.45
Revenue Growth
-69.91%
EPS Growth
-13.56%
Country
Singapore
Employees
200
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals

Jiutian Chemical Group Limited Business Overview & Revenue Model

Company Description

Jiutian Chemical Group Limited, established in Singapore in 1994, operates as an investment holding company with its primary chemical manufacturing and sales activities located in the People's Republic of China. The company's product portfolio encomp...

How the Company Makes Money

Jiutian Chemical Group Limited makes money primarily by manufacturing chemical products and selling them to industrial customers. Its revenue is mainly generated from (1) product sales: income from selling its manufactured chemical products, typicall...

Jiutian Chemical Group Limited Financial Statement Overview

Summary

Financial performance is critically weak. Revenue has collapsed to SGD 106M with deeply negative margins (gross -100%, net -155%). Operating and free cash flows are significantly negative, indicating unsustainable cash burn. The balance sheet provides a minor cushion with moderate leverage (D/E 0.28x), but equity is rapidly eroding due to persistent losses.

Income Statement

5Very Negative

Balance Sheet

25Negative

Cash Flow

5Very Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue393.13M108.43M243.76M598.56M2.43B2.17B
Gross Profit-147.20M-108.72M-82.26M-260.18M708.41M675.62M
EBITDA-141.98M-101.49M-118.22M-321.76M696.61M517.79M
Net Income-162.31M-239.63M-147.80M-344.64M490.50M324.90M
Balance Sheet
Total Assets1.42B626.61M1.05B1.29B1.99B1.89B
Cash, Cash Equivalents and Short-Term Investments698.48M198.16M400.41M529.62M1.11B773.55M
Total Debt234.88M127.62M289.32M265.88M134.64M228.18M
Total Liabilities469.16M248.45M427.02M523.23M764.65M1.08B
Stockholders Equity948.17M378.31M618.04M765.84M1.22B816.21M
Cash Flow
Free Cash Flow-356.18M-155.06M-171.63M-511.23M424.05M633.54M
Operating Cash Flow-328.39M-129.87M-81.58M-385.65M434.01M655.81M
Investing Cash Flow-27.72M-24.57M-89.54M-125.70M-9.85M-27.68M
Financing Cash Flow-53.04M-160.50M32.87M-732.00K-95.52M-110.89M

Jiutian Chemical Group Limited Technical Analysis

Technical Analysis SentimentPositive
Last Price0.01

Price Trends

50DMA0.02Positive
100DMA0.02Positive
200DMA0.02Positive

Market Momentum

MACD-0.00Negative
RSI54.27Neutral
STOCH333.33Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:C8R, the sentiment is Positive. The current price of 0.01 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a bullish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 54.27 is Neutral, neither overbought nor oversold. The STOCH value of 333.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SG:C8R.

Jiutian Chemical Group Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

SG:C8R against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SG:QESSG:QES72OutperformSGD 558.03M6.989.08%4.70%4.17%-12.40%
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
SG:C05SG:C0551NeutralSGD 35.69M-26.40-0.88%1.06%-7.25%95.72%
SG:M15SG:M1543NeutralSGD 11.35M-1.30-164.44%―25.81%-30.34%
SG:C8RSG:C8R39UnderperformSGD 29.83M-0.65-48.10%―-69.91%-13.56%
SG:5WVSG:5WV35UnderperformSGD 13.32M-11.25-81.29%―――

* Basic Materials Sector Average

Performance Comparison

-40%-20%0%20%SG:C8RSG:QESSG:C05SG:M15SG:5DSSG:5WVDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
SG:C8R and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
SG:C8RJiutian Chemical Group Limited0.01-0.01-46.43%
SG:QESChina Sunsine Chemical Holdings Ltd.0.57-0.09-13.14%
SG:C05Chemical Industries Far East Ltd.0.47-0.05-9.62%
SG:M15Matex International Limited0.020.000.00%
SG:5DSMegaChem Ltd.0.450.023.45%
SG:5WVAsiaPhos Limited0.010.000.00%

Jiutian Chemical Group Limited Corporate Events

Jiutian Chemical Adjusts Board Line-Up While Keeping Governance Framework Intact

Oct 19, 2026

Jiutian Chemical Group Limited has announced changes in its boardroom, highlighted by the resignation of non-executive and independent director Wang Zilong effective 3 November 2026 and the appointment of new non-executive and independent director Li...

Jiutian Chemical Cleared of Liability as Arbitration Claim Withdrawn

Aug 11, 2026

Jiutian Chemical Group Limited has announced that an arbitration claim filed against the company at the Shanghai International Economic and Trade Arbitration Commission has been withdrawn by the claimant. The arbitral tribunal accepted the withdrawal...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 25, 2026